Q&A: Iksuda Therapeutics: Leading the way on helping to advance care for ovarian and lung cancer patients

By |2022-02-18T10:20:49+00:00October 11th, 2019|Archive|

We talk to David Simpson, CEO at Iksuda Therapeutics about what they do, how

Read Article
Comments Off on Q&A: Iksuda Therapeutics: Leading the way on helping to advance care for ovarian and lung cancer patients

Biosphere tenant Iksuda Therapeutics presents first data on lead antibody drug conjugate, demonstrating effective tumour regression.

By |2022-02-18T10:20:26+00:00September 30th, 2019|Archive|

Iksuda Therapeutics (Iksuda), a developer of next generation Antibody Drug Conjugates (ADCs), today announced

Read Article
Comments Off on Biosphere tenant Iksuda Therapeutics presents first data on lead antibody drug conjugate, demonstrating effective tumour regression.

EU Logo
Northern Powerhouse Logo
NE LEP
Newcastle Council Logo
Newcastle Helix Logo

The Biosphere is part of the Newcastle Helix community.

It is part funded by the England European
Regional Development fund as part of the European Structural And Investment Funds Growth Programme 2014-2020 and the North East Local Growth Fund from HM Government, Administered by the North East Local Enterprise Partnership.

Get in touch
Request a callback
Skip to content
This Website is committed to ensuring digital accessibility for people with disabilitiesWe are continually improving the user experience for everyone, and applying the relevant accessibility standards.
Conformance status
Developed by AGHAI Web Development
Go to Top